Non-invasive tests (NIT)s for clinically significant portal hypertension (CSPH; hepatic venous pressure gradient [HVPG] ≥10mmHg) have predominantly been studied in patients with active HCV-infection. Investigations after HCV-cure are limited and yielded conflicting results. We conducted a pooled analysis to determine the diagnostic/prognostic utility of liver stiffness-measurement (LSM)/platelet count (PLT) in this setting.
Non-invasive tests for clinically significant portal hypertension after HCV cure
Zanetto, Alberto;Paolo Russo, Francesco;
2022
Abstract
Non-invasive tests (NIT)s for clinically significant portal hypertension (CSPH; hepatic venous pressure gradient [HVPG] ≥10mmHg) have predominantly been studied in patients with active HCV-infection. Investigations after HCV-cure are limited and yielded conflicting results. We conducted a pooled analysis to determine the diagnostic/prognostic utility of liver stiffness-measurement (LSM)/platelet count (PLT) in this setting.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
